Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	89.22	333.51	176.26
Graham Fair Price	-26.82	9.69	13.24
PEG	469.14	1.55	-0.27
Price/Book	3.96	4.09	3.94
Price/Cash Flow	102.97	254.89	125.58
Prices/Earnings	-84.85	-68.72	-37.17
Price/Sales	24.71	51.05	40.93
Price/FCF	102.97	254.89	125.58
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.34	0.45	0.47
Operating Margin	-2328.09	-0.13	< 0.005
ROA	43.12	-0.01	-0.02
ROE	-0.03	-0.01	43.76
ROIC	< 0.005	< 0.005	-388.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.12	-91.94
Dividends QOQ	< 0.005	< 0.005	-352.08
EBIT QOQ	0.95	-18.76	1877.37
EPS QOQ	-1.37	0.44	-67.52
FCF QOQ	0.04	-0.50	1242.22
Revenue QOQ	< 0.005	-0.19	3243.41
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	102.04	117.48	15.13
Days Sales Outstanding (DSO)	70.76	68.37	-3.38
Inventory Turnover	0.88	0.77	-13.14
Debt/Capitalization	0.23	0.23	1.16
Quick Ratio	1.14	1.18	3.16
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	17.15	16.74	-2.41
Cash	1.10	0.98	-10.87
Capex	-0.09	-0.11	-12.71
Free Cash Flow	0.54	0.27	-50.02
Revenue	1.65	1.34	-18.65
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.69	1.80	6.86
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.65	20.45	92.03
Naive Interpretation	Member

06 - Financial Health · Weak

Rating